Singapore markets closed

Biora Therapeutics, Inc. (BIOR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.1000-0.0700 (-5.98%)
At close: 04:00PM EDT
1.1300 +0.03 (+2.73%)
After hours: 07:37PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.1700
Open1.1600
Bid1.0600 x 100
Ask1.1600 x 100
Day's range1.0800 - 1.1675
52-week range0.7560 - 6.7000
Volume351,046
Avg. volume385,637
Market cap29.93M
Beta (5Y monthly)1.11
PE ratio (TTM)N/A
EPS (TTM)-10.1600
Earnings date13 May 2024 - 17 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est27.80
  • Insider Monkey

    Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2023 Earnings Call Transcript

    Biora Therapeutics, Inc. (NASDAQ:BIOR) Q4 2023 Earnings Call Transcript March 26, 2024 Biora Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Biora Therapeutics Fourth Quarter 2023 Financial Results Call. At this time, all participants are […]

  • Thomson Reuters StreetEvents

    Q4 2023 Biora Therapeutics Inc Earnings Call

    Q4 2023 Biora Therapeutics Inc Earnings Call

  • GlobeNewswire

    Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

    All performance targets achieved in single-ascending dose (SAD) cohorts of BT-600 clinical trial Results demonstrated targeted drug delivery and absorption in the colon, with 3-4 times lower drug levels in blood Remainder of BT-600 clinical trial progressing well and on schedule Management will host conference call and webcast today at 4:30 PM Eastern / 1:30 PM Pacific SAN DIEGO, March 26, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining t